BACKGROUND: Neural Wiskott-Aldrich syndrome protein (N-WASP) mediates migration
and invasion in cancer cells, but its expression and clinicopathologic and prognostic …

Abstract Background and Aims: Our previous study showed that small-for-size liver graft may
provide favorable micro-environment for tumor growth. GPx3, an anti-oxidant, not only …

Aim The selection criteria for patients with hepatocellular carcinoma (HCC) to undergo liver
transplantation should accurately predict posttransplant recurrence while not denying …

Hepatocellular carcinoma is one leading cause of cancer-related death and surgical
resection is still one of the major curative therapies. Recently, there has been a major effort …

Objective: To identify the risk factors for the presence of microvascular invasion (MVI) in
patients with solitary small hepatitis B related hepatocellular carcinoma (HCC). Methods …

Objective This study aims to analyze the outcomes of patients with Child-Pugh A class
cirrhosis and a single hepatocellular carcinoma (HCC) up to 5 cm in diameter who …

Methyl-CpG binding domain 2 (MBD2) leads to the silencing of methylated genes in cancer
cells and was implicated in the activation of prometastatic genes in hepatocellular …

Introduction The significance of bile duct tumor-associated thrombi in patients undergoing
transplantation for hepatocellular carcinoma (HCC) is controversial. Therefore, we …

There is a lack of data on incidental hepatocellular carcinoma (iHCC) in the setting of liver
transplantation (LT) in human immunodeficiency virus (HIV)–infected patients. This study …

Aim: Liver transplantation is the optimal treatment for a selected group of patients with
hepatocellular carcinoma (HCC). Post-transplant recurrence is common and markedly …